Developing an Injectable Nanofibrous Extracellular Matrix Hydrogel With an Integrin αvβ3 Ligand to Improve Endothelial Cell Survival, Engraftment and Vascularization is a research paper published in Frontiers in Bioengineering and Biotechnology (2020). On theSindex it has a DataRank of 0. It has been cited 22 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R03HD091601-01
Guinea pigs as a model of in utero stem cell therapy for spina bifida
National Institutes of Health
Grant: 5R01NS100761-02
Fetal Tissue Engineering to Treat Spina Bifida Before Birth
National Institutes of Health
Grant: 3P30CA093373-07S2
Cancer Center Support Grant - P30
NCI NIH HHS
Grant: P30 CA093373
NINDS NIH HHS
Grant: R01 NS100761
NICHD NIH HHS
Grant: R03 HD091601
Fields of Study
Keywords